Skip to the main content.
Other Therapy Areas

Extending our scientific depth across allergy, dermatology, ophthalmology, respiratory, women's health, and more.

Learn More →

Blog | Veristat Insightful Perspectives

Gain the latest insights and trends in clinical trials, patient recruitment, data analysis, adaptive design, regulatory submissions and approvals.

Posts about

Clinical Trial Regulations (5)

The Human Factor: Why Team Integration Makes or Breaks Marketing Applications

In the complex world of new drug applications (NDAs) and marketing authorization applications...

Evaluating Adaptive Trials: Do They Align with Your Study’s Goals and Requirements?

Innovative clinical trial approaches, including adaptive study designs, can play a key role in...

Monthly FDA Guidance and Regulatory News Review - February 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...

Unlocking Potential: Taking a Statistics-driven Approach to Clinical Trial Planning

Clinical trials are complex, and even well-designed studies may encounter challenges in...

Timeline Mastery: The Strategic Backbone of Marketing Application Success

In the intricate dance of preparing marketing applications, the timeline serves as a choreographer,...

The Right Track for Data Management Success

Data management plays a formative role in driving clinical development and supporting sponsors'...

Monthly FDA Guidance and Regulatory News Review - January 2025

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...

Multi-Regional Clinical Trials: The Latest Guidance from FDA

Planning and designing clinical trials conducted in multiple geographic or regulatory regions

Monthly FDA Guidance and Regulatory News Review - December 2024

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...

Monthly FDA Guidance and Regulatory News Review - November 2024

Each month, Veristat's regulatory team tracks and shares a selection of new Regulatory Guidance...